Insiders · Profile

GRYSKA DAVID W

Director at Definium Therapeutics · Executive Vice President, CFO at Incyte. Filing since 10 Apr 2017. CIK 0001202335

Company
Date
Role
Action
Shares
Amount
Of holding
5 Dec 2024
Director
Bought
2,500
$17.93K
14.4%
23 Aug 2024
Director
Bought
3,500
$20.93K
25.3%
21 Feb 2018
Executive Vice President, CFO
Sold, plan not stated
1,952
$167.01K
15.1%
5 Jan 2018
Executive Vice President, CFO
Sold, plan not stated
6,760
$668.36K
32.6%
2 Nov 2017
Executive Vice President, CFO
Sold, plan not stated
3,915
$413.54K
21.9%
30 Jun 2017
Executive Vice President, CFO
Sold, plan not stated
599
$77.71K
3.1%
12 Jun 2017
Executive Vice President, CFO
Sold, plan not stated
16,756
$1.95M
46.8%
28 Apr 2017
Executive Vice President, CFO
Sold, plan not stated
1,389
$172.60K
6.8%
10 Apr 2017
Executive Vice President, CFO
Sold, plan not stated
41,528
$5.73M
68.6%
9 decisions on file.